Mirabegron

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Mirabegron and local guidelines before prescribing.

Beta-3 agonist

Mechanism

Beta-3 agonist relaxing the detrusor.

Uses

Overactive bladder (alternative to antimuscarinics).

Dosing

Side effects

Hypertension, tachycardia, UTI, headache.

Interactions

CYP2D6 inhibitor raising metoprolol and digoxin levels.

Contraindications and cautions

Severe uncontrolled hypertension

Monitoring

BP

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose in severe renal or hepatic impairment

Overdose and reversal

Supportive

Special advice

Check BP before and during treatment; avoids anticholinergic cognitive burden.

More from the textbook: uses, cautions and other points
Where it is discussed in the book